TLX

Telix Pharmaceuticals Limited (TLX)

US
$ 18.8-2.19%

Price Chart

Key Statistics

Market Cap
$ 5.23B
P/E Ratio
173.44
Revenue (TTM)
$ 645.68M
Volume
28.85K
52W High
$ 30.36
52W Low
$ 13.61
Dividend Yield
0.00%
Beta
2.38

Technicals

50-Day MA
15.6043
200-Day MA
15.6043
52 Week High
30.36
52 Week Low
13.61

About TLX

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare dis.

Employees
N/A
Headquarters
North Melbourne, VIC
CEO
Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96